Pharmaceutical giant Johnson & Johnson has reached a landmark settlement with thousands of plaintiffs in the United States, agreeing to pay a staggering $5.5 billion to resolve nearly 70,000 lawsuits alleging that its popular talc-based baby powder caused cancer. The lawsuits, which have been ongoing for years, claim that the company's talc-based products contained asbestos, a known carcinogen, leading to cases of ovarian cancer and mesothelioma in women who used the powder. The massive settlement is one of the largest payouts in the company's history and marks a significant victory for the plaintiffs who have been fighting for justice. As the company faces mounting evidence and mounting pressure, this settlement is likely to have far-reaching implications for the pharmaceutical industry and the way companies address product safety concerns.
Johnson & Johnson agrees to pay $5.5bn to settle nearly 70,000 US lawsuits over talc-based baby powder cancer claims.
